MDPI and ACS Style
Basoulis, D.; Tsakanikas, A.; Gkoufa, A.; Bitsani, A.; Karamanakos, G.; Mastrogianni, E.; Georgakopoulou, V.E.; Makrodimitri, S.; Voutsinas, P.-M.; Lamprou, P.;
et al. Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study. Viruses 2023, 15, 1515.
https://doi.org/10.3390/v15071515
AMA Style
Basoulis D, Tsakanikas A, Gkoufa A, Bitsani A, Karamanakos G, Mastrogianni E, Georgakopoulou VE, Makrodimitri S, Voutsinas P-M, Lamprou P,
et al. Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study. Viruses. 2023; 15(7):1515.
https://doi.org/10.3390/v15071515
Chicago/Turabian Style
Basoulis, Dimitrios, Aristeidis Tsakanikas, Aikaterini Gkoufa, Aikaterini Bitsani, Georgios Karamanakos, Elpida Mastrogianni, Vasiliki E. Georgakopoulou, Sotiria Makrodimitri, Pantazis-Michail Voutsinas, Panagiota Lamprou,
and et al. 2023. "Effectiveness of Oral Nirmatrelvir/Ritonavir vs. Intravenous Three-Day Remdesivir in Preventing Progression to Severe COVID-19: A Single-Center, Prospective, Comparative, Real-Life Study" Viruses 15, no. 7: 1515.
https://doi.org/10.3390/v15071515